Parnell Pharmaceuticals Holdings Ltd
PARNF · OTC
12/31/2016 | 9/30/2016 | 6/30/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $2 | $4 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $3 | $9 | $7 |
| Inventory | $4 | $4 | $4 | $3 |
| Other Curr. Assets | $4 | $1 | $0 | $4 |
| Total Curr. Assets | $16 | $10 | $17 | $17 |
| Property Plant & Equip (Net) | $12 | $12 | $12 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $19 | $17 | $17 | $17 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $31 | $30 | $29 | $29 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $48 | $39 | $47 | $46 |
| Liabilities | – | – | – | – |
| Payables | $6 | $8 | $8 | $4 |
| Short-Term Debt | $0 | $7 | $8 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $1 | $1 | $3 |
| Total Curr. Liab. | $9 | $16 | $17 | $10 |
| LT Debt | $30 | $10 | $12 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $31 | $11 | $13 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $27 | $30 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $64 | $63 | $63 | $55 |
| Retained Earnings | -$55 | -$52 | -$46 | -$34 |
| AOCI | -$0 | -$2 | -$0 | -$2 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $8 | $12 | $17 | $20 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $48 | $39 | $47 | $46 |
| Net Debt | $23 | $15 | $16 | $12 |